Posted on by — Leave a comment

Neuropathic Ocular Pain Market to Register Incremental Growth During the Forecast Period (2022-2032), Asserts DelveInsight | Key Companies – Pharmaleads, Novartis Pharmaceutical, OKYO Pharma Limited

Neuropathic Ocular Pain Market to Register Incremental Growth During the Forecast Period (2022-2032), Asserts DelveInsight | Key Companies - Pharmaleads, Novartis Pharmaceutical, OKYO Pharma Limited
DelveInsight’s “Neuropathic Ocular Pain Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Neuropathic Ocular Pain, historical and forecasted epidemiology as well as the Neuropathic Ocular Pain market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Neuropathic Ocular Pain market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Neuropathic Ocular Pain pipeline products will significantly revolutionize the Neuropathic Ocular Pain market dynamics.  

 

Neuropathic Ocular Pain Overview 

The International Association for the Study of Pain defines neuropathic pain as “pain initiated or caused by a primary lesion or dysfunction of the nervous system.” The neuropathic pain diagnosis requires confirmation of injury or disease affecting somatosensory pathways of the peripheral and/or central nervous systems (CNS).

Neuropathic pain can also occur in the ocular or cornea region, which is the most richly innervated tissue in the body. Neuropathic ocular pain/neuropathic corneal pain (NOP/NCP) is a condition in which individuals have ocular surface pain generated by nerve dysfunction.

 

Neuropathic Ocular Pain Symptoms  

Dryness (with minimal or no relief from over-the-counter lubricating drops), scorching, shooting, pressure-like pain, alien body sensation, grittiness, aching, stabbing or cutting sensation, and/or throbbing are some of the Neuropathic Ocular Pain symptoms.

 

Some of the key facts of the Neuropathic Ocular Pain Market Report: 

  • The Neuropathic Ocular Pain market size is anticipated to grow with a significant CAGR during the study period (2019-2032)  
  • According to the National organization for rare disorders (NORD, n.d.), understanding the epidemiology of Neuropathic Ocular Pain is challenging as data regarding symptoms is linked with various factors 
  • According to Crane et al., it is estimated that dry eye disease has a prevalence of 15% in the general United States population 
  • The prevalence of Neuropathic Ocular Pain ranges from 5% to 30% in patients aged above 50 years in the 7MM 
  • Key Neuropathic Ocular Pain Companies: Pharmaleads, Novartis Pharmaceutical, OKYO Pharma Limited, and others
  • Key Neuropathic Ocular Pain Therapies: SAF312, PL265, OK-201, and others 
  • The Neuropathic Ocular Pain epidemiology based on gender analyzed that the proportion of females with neuropathic ocular pain is higher than men 

 

Get a Free sample for the Neuropathic Ocular Pain Market Report 

 

Key benefits of the Neuropathic Ocular Pain Market report:

  1. Neuropathic Ocular Pain market report covers a descriptive overview and comprehensive insight of the Neuropathic Ocular Pain Epidemiology and Neuropathic Ocular Pain market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
  2. The Neuropathic Ocular Pain market report provides insights on the current and emerging therapies.
  3. Neuropathic Ocular Pain market report provides a global historical and forecasted market covering drug outreach in 7MM.
  4. The Neuropathic Ocular Pain market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Neuropathic Ocular Pain market.

 

Discover more about therapies set to grab major Neuropathic Ocular Pain market share @ Neuropathic Ocular Pain market forecast 

 

Neuropathic Ocular Pain Epidemiology Segmentation:

The Neuropathic Ocular Pain market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

  • Total Prevalence of Neuropathic Ocular Pain
  • Prevalent Cases of Neuropathic Ocular Pain by severity
  • Gender-specific Prevalence of Neuropathic Ocular Pain
  • Diagnosed Cases of Episodic and Chronic Neuropathic Ocular Pain 

 

Neuropathic Ocular Pain Market  

The dynamics of the Neuropathic Ocular Pain market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032. 

“The pipeline of emerging therapies for NOP has limited candidates. The possible reason behind this scarcity could be a lack of research and awareness about the disease in the market. Pharmaceutical companies are investigating products like SAF312, PL265, and some others. These products are in the mid and early stages of development.” 

 

Download the report to understand which factors are driving Neuropathic Ocular Pain epidemiology trends @ Neuropathic Ocular Pain Epidemiological Insights 

 

Neuropathic Ocular Pain Therapies

  • SAF312
  • PL265
  • OK-201

 

Neuropathic Ocular Pain Key Companies  

  • Pharmaleads 
  • Novartis Pharmaceutical
  • OKYO Pharma Limited

 

Scope of the Neuropathic Ocular Pain Market Report

  • Study Period: 2019–2032
  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
  • Key Neuropathic Ocular Pain Companies: Pharmaleads, Novartis Pharmaceutical, OKYO Pharma Limited, and others
  • Key Neuropathic Ocular Pain Therapies: SAF312, PL265, OK-201, and others
  • Therapeutic Assessment: Neuropathic Ocular Pain current marketed and Neuropathic Ocular Pain emerging therapies
  • Neuropathic Ocular Pain Market Dynamics:  Neuropathic Ocular Pain market drivers and barriers 
  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
  • Unmet Needs, KOL’s views, Analyst’s views, Neuropathic Ocular Pain  Market Access and Reimbursement 

 

Table of Contents 

1. Neuropathic Ocular Pain Market Report Introduction

2. Executive Summary for Neuropathic Ocular Pain

3. SWOT analysis of Neuropathic Ocular Pain

4. Neuropathic Ocular Pain Patient Share (%) Overview at a Glance

5. Neuropathic Ocular Pain Market Overview at a Glance

6. Neuropathic Ocular Pain Disease Background and Overview

7. Neuropathic Ocular Pain Epidemiology and Patient Population

8. Country-Specific Patient Population of Neuropathic Ocular Pain 

9. Neuropathic Ocular Pain Current Treatment and Medical Practices

10. Neuropathic Ocular Pain Unmet Needs

11. Neuropathic Ocular Pain Emerging Therapies

12. Neuropathic Ocular Pain Market Outlook

13. Country-Wise Neuropathic Ocular Pain Market Analysis (2019–2032)

14. Neuropathic Ocular Pain Market Access and Reimbursement of Therapies

15. Neuropathic Ocular Pain Market drivers

16. Neuropathic Ocular Pain Market barriers

17.  Neuropathic Ocular Pain Appendix

18. Neuropathic Ocular Pain Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

To know more about Neuropathic Ocular Pain treatment, visit @ Neuropathic Ocular Pain Medications

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/